Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,730.68
(
0.47%
)
US TECH 100
24,205.44
(
0.79%
)
Dow Jones
47,144.03
(
0.42%
)
Brent Oil
99.12
(
0.83%
)
Bitcoin
74,283.40
(
-0.75%
)
News Focus
News Focus

Replies to post #127283 on Biotech Values

Replies to #127283 on Biotech Values
icon url

DewDiligence

09/24/11 2:36 PM

#127286 RE: mcbio #127283

By and large, non-substitutable FoB’s are a bad business proposition, IMHO.

Is it your expectation that MNTA may be the only company with the technology to pursue fully-substitutable biogenerics?

To my knowledge, no other company claims to be interested in or capable of doing it.
icon url

DewDiligence

05/11/12 1:49 PM

#141803 RE: mcbio #127283

MNTA’s presenter at FoB panel, CMO James Roach, presses for interchangeability, which is consistent with MNTA’s longstanding stated goal (#msg-26837144).